An evaluation suggested got no overall net clinical benefit in patients receiving the drug in the study , the companies said in a statement distributed by Business Wire .
An evaluation of 240 arthritis patients suggested got no overall net clinical benefit from taking the medicine , the companies said in a statement distributed by Business Wire .